Relative Energy Deficiency in Rowers

June 11, 2024 updated by: Poznan University of Physical Education

Relative Energy Deficiency in Females and Males Rowers - Observational Study

This study aims to learn about relative energy deficiency in male and female rowers at the end of the direct sport preparation phase of the annual training cycle. The main questions:

- How will energy intake influence leptin, cortisol levels, mood, gut discomfort, and permeability? The observational study involves male and female rowers from the Polish rowing team.

Participants will perform 2000 meter ergometer test and 6000 ergometer test in annual training cycle. Researchers will compare outcomes from both tests.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Anna Skarpańska-Stejnborn, Profesor

Study Locations

    • Lubuskie
      • Gorzów Wielkopolski, Lubuskie, Poland, 66-400
        • Poznan University of Physical Education, Faculty of Sport Sciences in Gorzow
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Male rowers age 18 - 22 years.

Description

Inclusion Criteria:

  • Membership in Polish Rowing Team,
  • minimum five years of training,
  • total training time minimum of 240 minutes,
  • filling out a food diary,
  • finishing 2000-meter ergometer test.

Exclusion Criteria:

  • Probiotics within the last three months,
  • prebiotics within the last three months
  • antibiotic therapy within the last three months,
  • dietary regime,
  • gastrointestinal diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
male and female rowers
Rowers will perform 2000m ergometer test.A 2,000-m time trial is a standard test used to assess performance in rowers.
Rowers will perform 2000m ergometer test. A 2,000-meter trial is a standard test used to assess performance in rowers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
-FABP (intestinal fatty acid binding protein)to measure epithelial wall injury
Time Frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
I-FABP concentration measured in blood [ng/ml] using commercially availableenzyme-linked immunosorbent assays
Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
Leptin to measure long-term energy balance
Time Frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
Leptin concentration measured in blood [ng/ml] using commercially availableenzyme-linked immunosorbent assays
Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
Cortisol to measure stress
Time Frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
Stress hormone concentration measured in blood [ng/ml] using commercially available enzyme-linked immunosorbent assays
Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
sCD14 multifunctional lipopolysaccharide receptor
Time Frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
sCD14 concentration measured in blood [ug/ml] using commercially available enzyme-linked immunosorbent assays
Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
Claudin to measure tight junction leakage
Time Frame: Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
Claudin concentration measured in blood [ng/ml] using commercially available enzyme-linked immunosorbent assays
Blood samples was taken from the cubital vein at three-time points: before each stress test (after overnight fasting) up to one hour after getting up, 1 minute after the test, and 3-hour recovery period
POMS
Time Frame: day before the test
Profile of Mood States
day before the test
REST-Q sport
Time Frame: day before the test
Recovery-Stress questionnaire for Athletes
day before the test

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
energy
Time Frame: Time Frame: whole day (24hours) before test, in the morning before the test
energy [kcal ]of food intake measured by food diary
Time Frame: whole day (24hours) before test, in the morning before the test
protein
Time Frame: Time Frame: whole day (24hours) before test, in the morning before the test
protein [g ]of food intake measured by food diary
Time Frame: whole day (24hours) before test, in the morning before the test
fat
Time Frame: Time Frame: whole day (24hours) before test, in the morning before the test
fat [g ]of food intake measured by food diary
Time Frame: whole day (24hours) before test, in the morning before the test
carbohydrate
Time Frame: Time Frame: whole day (24hours) before test, in the morning before the test
carbohydrate [g ]of food intake measured by food diary
Time Frame: whole day (24hours) before test, in the morning before the test
fiber
Time Frame: Time Frame: whole day (24hours) before test, in the morning before the test
fiber [g ]of food intake measured by food diary
Time Frame: whole day (24hours) before test, in the morning before the test
Body mass
Time Frame: in the morning before the test up to 1 hour after getting up
Body mass [kg] measured by electronic scale to the nearest 0,05 kg (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan)
in the morning before the test up to 1 hour after getting up
Body fat
Time Frame: in the morning before the test up to 1 hour after getting up
Body fat [%] measured by electronic scale (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan)
in the morning before the test up to 1 hour after getting up
Total body water
Time Frame: in the morning before the test up to 1 hour after getting up
Body water [%] measured by electronic scale (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan)
in the morning before the test up to 1 hour after getting up
Lean body mass
Time Frame: in the morning before the test up to 1 hour after getting up
Lean body mass [kg] measured by electronic scale (Tanita BC 418 MA Tanita Corporation, Tokyo, Japan)
in the morning before the test up to 1 hour after getting up
Height
Time Frame: in the morning before the test up to 1 hour after getting up
[cm] measured by high meter
in the morning before the test up to 1 hour after getting up
Self reported scale of gastrointestinal symptoms e.g.burping, heartburn, flatulence, abdominal pain, the urge to reiterate, vomiting, diarrhoea, nausea, dizziness, and stitch
Time Frame: up to 1 hours after the test
10-point scale where 10 was the symptom with the greatest severity
up to 1 hours after the test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Anna Skarpańska-Stejnborn, Profesor, Poznan University of Physical Education

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 20, 2024

Primary Completion (Estimated)

June 26, 2024

Study Completion (Estimated)

June 30, 2024

Study Registration Dates

First Submitted

June 5, 2024

First Submitted That Met QC Criteria

June 10, 2024

First Posted (Actual)

June 11, 2024

Study Record Updates

Last Update Posted (Actual)

June 13, 2024

Last Update Submitted That Met QC Criteria

June 11, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • REDs2024

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mood Disorders

Clinical Trials on 2000 meter ergometer test

Subscribe